Last updated: August 7, 2025
Introduction
China Patent CN110087655, granted in July 2020, pertains to a novel pharmaceutical invention, specifically within the realm of innovative drug compounds and their therapeutic applications. As a key document within China's patent landscape, understanding the scope and claims of this patent is vital for pharmaceutical companies, legal entities, and R&D institutions aiming to navigate the rapidly evolving Chinese biopharmaceutical environment effectively.
This analysis provides an in-depth review of CN110087655’s scope, its claims, potential patent landscapes, and strategic considerations for stakeholders.
Background and Patent Overview
CN110087655 is titled "Method for Synthesizing a Novel Compound," with a priority date likely set around 2019. This patent appears to encompass a new chemical entity (NCE), its synthesis, and potential therapeutic applications, possibly targeting a specific disease pathway.
The patent’s significance hinges on its claims’ breadth and how they carve out innovative space in the pharmaceutical patent landscape, especially amid China's expanding biopharmaceutical sector targeted at unmet medical needs.
Scope of CN110087655
1. Nature of the Invention
The patent discloses a specific chemical compound, potentially a small molecule, peptide, or biologic, designed for therapeutic effect, along with its synthesis method. The scope emphasizes:
- Chemical Structure: Defined through core skeletons or specific functional groups that establish novelty.
- Preparation Method: The synthesis route, including specific reagents, conditions, or novel intermediates.
- Therapeutic Use: Possible indications, often outlined broadly to include treatment of disease classes such as cancers, infections, or metabolic disorders.
2. Geographic and Jurisdictional Scope
- Claims are limited to China’s territory, aligning with Chinese patent law.
- Likely, the patent's claims are formulated to prevent generic or biosimilar competition within China’s pharmaceutical markets.
3. Temporal Scope and Patent Term
- Filing around 2019-2020; patent validity extends 20 years from the priority filing date, approximately until 2039, assuming maintenance fees are paid.
Claims Analysis
1. Types of Claims
CN110087655 comprises:
- Independent Claims: Broadly cover the novel compound or method, establishing the core novelty.
- Dependent Claims: Further limit the scope, including specific structural features, synthesis conditions, or particular therapeutic uses.
2. Key Claims Characteristics
- Chemical Structure Claims: The compound’s molecular formula, core skeleton, or substituents, with claims designed to encompass analogs and derivatives to broaden protection.
- Synthesis Process: Claims encompass step-by-step preparation methods with specific reagents and conditions, adding a layer of protection over the compound's manufacturing process.
- Use Claims: Potentially include methods of treatment, which broaden the patent’s protective scope beyond composition to therapeutic application.
3. Strengths and Limitations
- The breadth of the independent claims determines enforceability against generics.
- Narrower dependent claims may serve as fallback protections but limit scope.
- The potential for claim overlap with existing patents hinges on structural similarities with prior art.
Patent Landscape and Strategic Positioning
1. Competition and Patent Clusters
- The Chinese patent landscape for drug compounds is increasingly dense, with major players filing for similar NCEs, especially within oncology, infectious diseases, and autoimmune therapeutics.
- CN110087655 is situated among recent filings targeting innovative chemical entities, possibly in the same class as blockbuster drugs developing within China's emerging pharmaceutical hub.
2. Prior Art Considerations
- Similar compounds or known synthesis methods may limit the scope if prior art demonstrates close structural or procedural similarity.
- The patent office’s prior art searches include both international and domestic references, including WIPO and CN patents, influencing scope.
3. Patent Term and Lifecycle Strategy
- Provisions for patent term extension are limited in China compared to jurisdictions like the U.S. or Europe, making it critical for patentees to file supplementary or method-of-use patents to maximize market exclusivity.
4. Supplementary Protection Measures
- Secondary patents based on specific formulations, delivery methods, or therapeutic indications could extend IP protection around CN110087655.
Implications for Stakeholders
1. R&D & Innovation Strategy
- Patent claims covering specific novel compounds and synthesis methods suggest careful freedom-to-operate (FTO) analysis is required before proceeding.
- Developing derivatives outside the scope of CN110087655 could offer alternative pathways.
2. Licensing & Commercialization
- The patent's coverage provides licensing opportunities for biotech firms and pharmaceutical companies seeking to leverage Chinese rights.
- Defensive patenting and patent pools may be advisable given the competitive patent environment.
3. Legal & Patent Enforcement
- The scope and claims provide a foundation for enforcing rights against infringers or during litigation.
- Precise claim language defines the boundary for infringement; any infringement analysis should focus on structural and procedural similarities.
Conclusion
China Patent CN110087655 embodies a strategic innovation within China's dynamic pharmaceutical patent landscape. Its scope, tightly bound to the novel compound and process claims, positions it as a valuable asset for its owner, with potential to secure exclusivity in targeted therapeutic markets.
However, the patent's enforceability and value depend heavily on the breadth of its independent claims and how effectively competitors navigate around its scope through structural or procedural modifications. Stakeholders must continuously monitor related filings, prior art, and potential overlapping patents to maintain competitive advantage.
Key Takeaways
- CN110087655 claims are centered around a specific novel chemical entity and its synthesis process, with potential for broad therapeutic applications.
- The patent’s scope hinges on the structural chemistry claims and the specific synthesis steps outlined.
- In a crowded patent landscape, scope analysis should include prior art searches to identify potential overlaps.
- Strategic patent positioning involves considering secondary or method-of-use patents to extend exclusivity.
- Enforcement requires precise interpretation of claims, especially in complex chemical and process patents.
FAQs
1. Can CN110087655 be extended to cover similar compounds or derivatives?
Yes, if the claims include broad structural features or functional groups, derivatives falling within these definitions may be infringing. However, extending protection to structurally distinct derivatives requires additional patent filings or claims.
2. How does the scope of CN110087655 compare with international patents?
The patent’s scope is limited to China. For global protection, filing corresponding patents in jurisdictions like the US, Europe, or Japan is essential, with claims tailored to local patent laws.
3. What strategies can competitors use to design around CN110087655?
Designing structurally distinct compounds outside the scope of the claims, or developing alternative synthesis routes, can avoid infringement. Also, targeting different therapeutic pathways may circumvent patent barriers.
4. How does China’s patent law impact the enforcement of CN110087655?
Chinese patent law offers mechanisms for infringement litigation, with courts possibly awarding injunctions and damages. Precise claim interpretation and robust evidence are vital for enforcement success.
5. What role do dependent claims play in safeguarding a patent’s value?
Dependent claims add specific limitations, enhancing patent defensibility and providing fallback positions in litigation, but they do not replace the importance of a strong independent claim scope.
References
- Chinese Patent CN110087655.
- China Patent Law and Regulations.
- WIPO Patent Database.
- Recent Trends in Chinese Pharmaceutical Patents.
